Literature DB >> 20640531

Differential roles of PKA and Epac on the production of cytokines in the endotoxin-stimulated primary cultured microglia.

Jian Liu1, Xin Zhao, Jianping Cao, Qingsheng Xue, Xiaomei Feng, Xuesheng Liu, Fujun Zhang, Buwei Yu.   

Abstract

To further understand the anti-inflammatory effect of adenosine cyclic 3',5'-monophosphate (cAMP), we examined the effect of protein kinase A (PKA) and cAMP-responsive guanine nucleotide exchange factor (Epac) on the transcription and production of cytokines and on the activity of mitogen-activated protein kinases (MAPK) p38 and glycogen synthase kinase-3β (GSK-3β) in endotoxin-treated rat primary cultured microglia. The PKA specific agonist N6-benzoyladenosine-3,5-cAMP (6-Bnz-cAMP) not only inhibited the transcription and production of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) but also enhanced the transcription and expression of IL-10, while the Epac selective analog 8-(4-chlorophenylthio)-2-O-methyladenosine-3,5-cAMP (8-pCPT-2'-O-Me-cAMP) merely repressed the TNF-α expression. Western blots assays indicated that 6-Bnz-cAMP significantly inhibited lipopolysaccharide-induced activation of both p38 and GSK-3β in a dose-dependent manner; in contrast, 8-pCPT-2'-O-Me-cAMP only slightly repressed GSK-3β activity at large doses. Pretreatment with H-89, a specific PKA antagonist, could completely reverse the effect of 6-Bnz-cAMP on cytokines expressions and kinases activities but had no effect on the performance of 8-pCPT-2'-O-Me-cAMP. Our findings indicate that PKA and Epac exert differential effect on the expression of inflammatory cytokines such as TNF-α, IL-1β, and IL-10, possibly owing to the different effects on the downstream effectors, MAPK p38, and GSK-3β.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640531     DOI: 10.1007/s12031-010-9426-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  24 in total

Review 1.  Immune function of microglia.

Authors:  F Aloisi
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

Review 2.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  Neuroscience. The dark side of glia.

Authors:  Greg Miller
Journal:  Science       Date:  2005-05-06       Impact factor: 47.728

4.  Epac1-mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells.

Authors:  Eun-Yi Moon; Su-Young Oh; Gyoon-Hee Han; Chul-Sang Lee; Song-Kyu Park
Journal:  J Neurosci Res       Date:  2005-07-01       Impact factor: 4.164

Review 5.  Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation.

Authors:  Laura Dugo; Marika Collin; Christoph Thiemermann
Journal:  Shock       Date:  2007-02       Impact factor: 3.454

Review 6.  Microglia biology in health and disease.

Authors:  Gwenn A Garden; Thomas Möller
Journal:  J Neuroimmune Pharmacol       Date:  2006-03-25       Impact factor: 4.147

7.  Selective modulation of BV-2 microglial activation by prostaglandin E(2). Differential effects on endotoxin-stimulated cytokine induction.

Authors:  T V Petrova; K T Akama; L J Van Eldik
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

8.  A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2.

Authors:  Huie Jing; Jui-Hung Yen; Doina Ganea
Journal:  J Biol Chem       Date:  2004-10-21       Impact factor: 5.157

9.  Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells.

Authors:  Wei-Ching Huang; Yee-Shin Lin; Chi-Yun Wang; Cheng-Chieh Tsai; Hsiang-Chi Tseng; Chia-Ling Chen; Pei-Jung Lu; Po-See Chen; Li Qian; Jau-Shyong Hong; Chiou-Feng Lin
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

10.  Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-kappaB pathway.

Authors:  Yang Xue; Ying Wang; De-chun Feng; Bao-guo Xiao; Ling-yun Xu
Journal:  Acta Pharmacol Sin       Date:  2008-02       Impact factor: 6.150

View more
  11 in total

1.  Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity.

Authors:  Shekher Mohan; Shuh Narumiya; Sylvain Doré
Journal:  Neurotoxicology       Date:  2014-11-13       Impact factor: 4.294

2.  Protective Effect of Quercetin in LPS-Induced Murine Acute Lung Injury Mediated by cAMP-Epac Pathway.

Authors:  Xue-Feng Wang; Shun-de Song; Ya-Jun Li; Zheng Qiang Hu; Zhe-Wen Zhang; Chun-Guang Yan; Zi-Gang Li; Hui-Fang Tang
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

3.  siRNA-mediated silencing of phosphodiesterase 4B expression affects the production of cytokines in endotoxin-stimulated primary cultured microglia.

Authors:  Hao Cheng; Zhifang Wu; Xiaoyun He; Qingzhen Liu; Hongbin Jia; Yan Di; Qing Ji
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

4.  EP2 receptor signaling pathways regulate classical activation of microglia.

Authors:  Yi Quan; Jianxiong Jiang; Ray Dingledine
Journal:  J Biol Chem       Date:  2013-02-12       Impact factor: 5.157

5.  Epac1 deficiency inhibits basic fibroblast growth factor-mediated vascular smooth muscle cell migration.

Authors:  Yuko Kato; Utako Yokoyama; Takayuki Fujita; Masanari Umemura; Tetsuo Kubota; Yoshihiro Ishikawa
Journal:  J Physiol Sci       Date:  2018-08-06       Impact factor: 2.781

Review 6.  Balancing the immune response in the brain: IL-10 and its regulation.

Authors:  Diogo Lobo-Silva; Guilhermina M Carriche; A Gil Castro; Susana Roque; Margarida Saraiva
Journal:  J Neuroinflammation       Date:  2016-11-24       Impact factor: 8.322

7.  Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice.

Authors:  Li Liu; Youde Jiang; Adam Chahine; Elizabeth Curtiss; Jena J Steinle
Journal:  Mol Vis       Date:  2017-01-25       Impact factor: 2.367

Review 8.  Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?

Authors:  Annette J Theron; Helen C Steel; Gregory R Tintinger; Charles Feldman; Ronald Anderson
Journal:  Drug Des Devel Ther       Date:  2013-11-22       Impact factor: 4.162

9.  A G protein-coupled α7 nicotinic receptor regulates signaling and TNF-α release in microglia.

Authors:  Justin R King; Trudy C Gillevet; Nadine Kabbani
Journal:  FEBS Open Bio       Date:  2017-08-07       Impact factor: 2.693

10.  β2-Adrenoceptor Activation Stimulates IL-6 Production via PKA, ERK1/2, Src, and Beta-Arrestin2 Signaling Pathways in Human Bronchial Epithelia.

Authors:  Rui-Gang Zhang; Ya Niu; Ke-Wu Pan; Hao Pang; Chun-Ling Chen; Chung-Yin Yip; Wing-Hung Ko
Journal:  Lung       Date:  2021-11-01       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.